Why ApoB jumps around menopause
On this page
In the year before and the year after their last period, women’s ApoB, LDL and total cholesterol jump in a way that getting older doesn’t explain. That comes from SWAN, a US study that followed 1,054 women through menopause with a checkup every year. The same food changes still work, and when you test makes more difference than usual.
What we’d do
If your ApoB rose in your late 40s or early 50s, check the timing before you blame your diet. Note the date of your last period and compare tests from the same side of it. Make the same changes anyone would, less saturated fat and more plant protein, and retest a few months after your periods have stopped for good. If your menopause came before 45, tell your doctor, since the 2026 guideline counts that as something that raises heart risk.
If you remember three things
- It’s a step, and it comes at menopause. In SWAN, only total cholesterol, LDL and ApoB jumped within a year of the last period.
- Time your tests. Two results a year apart that straddle the last period can show a rise that isn’t your food.
- The goals don’t change. A rise caused by menopause raises the count the same as any other rise.
Why it catches women off guard
A lot of women eat the same way at 52 as at 47 and get a very different lipid panel. The natural guess is that it’s age, or that something about their eating slipped. Both guesses send people looking in the wrong place. The 2026 US guideline lists the menopausal transition among the normal body changes that raise LDL, next to pregnancy.
The study that separated age from menopause
Age and menopause arrive together, so for years it was hard to tell which one raised cholesterol. SWAN, the Study of Women’s Health Across the Nation, was built to pull them apart. It enrolled 3,302 women in midlife, from African American, Chinese, Hispanic, Japanese and white backgrounds, and saw them once a year.
After 10 yearly exams, 1,054 of them had reached a natural last period without hormone therapy before it. The researchers then asked a simple question about each risk factor. Did it climb in a straight line with age, or did it jump around the last period?
Most risk factors, including blood pressure and blood sugar, followed age. Only three jumped in the year before and the year after the last period: total cholesterol, LDL and ApoB. The pattern was the same across all five groups of women. The researchers wrote that women “experience a unique increase in lipids at the time of the FMP”, the final menstrual period.
A step in the middle of a ramp
Picture walking up a gentle ramp. Each year of age moves you up a little, and you barely notice. Around menopause there’s a single step in the middle of the ramp. If you measured your height once before the step and once after, you’d think you’d climbed a lot that year. You did, and most of it came from the step.
Timing your tests around it
A single jump is easy to misread. If your last two tests were a year apart and your last period fell between them, part of any rise is likely the step. Your ApoB also wobbles about 6.4% from test to test on its own, so a small change in either direction can be noise.
- Write down the date of your last period. You’ll only know it was the last one looking back, so keep a note of each one.
- Compare like with like. Two tests on the same side of the step tell you about your food. Two tests that straddle it mostly tell you about menopause.
- Retest after the step. A few months after your periods have stopped, test again at the same lab to see your new starting point.
- Use the retest tool. Did my ApoB really change? has a box for periods stopping between tests.
What still works
The food changes that lower ApoB were tested in adults across these ages. The feeding trial that sized saturated fat and plant protein included men and women aged 21 to 65, and halving saturated fat took ApoB down about 6 to 7 mg/dL in four weeks. Beans, lentils, nuts and soy in place of meat took off about 3 to 4. Nothing about menopause stops those from working. The twelve week plan sets them out week by week.
- Under 60 very high risk
- Under 70 high risk
- Under 90 borderline or intermediate risk
- 120 raises risk
- 140 severe
mg/dL over g/L. Rungs from the National Lipid Association (2024), matched to the 2026 US guideline's LDL goals. Ticks from the 2026 guideline.
Early menopause and your pregnancy history
The 2026 guideline says it’s reasonable for doctors to consider some reproductive history when deciding whether to start cholesterol treatment. That includes menopause before 45, and pregnancies with preeclampsia, high blood pressure, gestational diabetes or a preterm birth. If any of those apply to you, mention them when you talk about your ApoB.
During pregnancy itself, cholesterol rises as a normal part of carrying a baby, and the usual goals don’t apply. Take any result from pregnancy to your midwife or doctor.
What nobody knows yet
SWAN measured the jump, not heart attacks. Nobody has shown whether a rise caused by menopause carries exactly the same risk per point as a rise from diet or genes. The gene research suggests it should, since in a study of 654,783 people the benefit of a lower ApoB was the same per 10 points whichever fat the genes moved. We’d treat a menopause rise like any other.
Ask your doctor about hormone therapy and what it does to your numbers. cholesterol.guide covers what menopause does to the rest of your panel.

6 sources
- Matthews KA and others, Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? (SWAN), JACC, 2009pubmed.ncbi.nlm.nih.gov
- Blumenthal RS, Morris PB, Gaudino M and others, 2026 ACC/AHA guideline on the management of dyslipidemia, JACC and Circulation, 13 March 2026doi.org
- The same guideline, full text, Circulation, 2026api.iscpcardio.org
- Bergeron N, Chiu S, Williams PT, King SM, Krauss RM, red meat, white meat and plant protein on high and low saturated fat diets, a feeding trial in 113 adults, American Journal of Clinical Nutrition, 2019pmc.ncbi.nlm.nih.gov
- Ference BA and others, Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease, JAMA, 2019pmc.ncbi.nlm.nih.gov
- Kafonek SD, Derby CA, Bachorik PS, Biological variability of lipoproteins and apolipoproteins in patients referred to a lipid clinic, Clinical Chemistry, 1992pubmed.ncbi.nlm.nih.gov